Suppr超能文献

小鼠同基因混合淋巴细胞反应的体内调节

In vivo regulation of the murine syngeneic mixed lymphocyte reaction.

作者信息

Bryson J S, Jones L A, Caywood B E, Kaplan A M

机构信息

Department of Microbiology and Immunology, University of Kentucky Medical Center, Lexington 40536-0084.

出版信息

Cell Immunol. 1990 Aug;129(1):138-50. doi: 10.1016/0008-8749(90)90193-u.

Abstract

Previous work from this laboratory has suggested that a CD8+ T suppressor (Ts) cell network regulated the murine syngeneic mixed lymphocyte reaction (SMLR). We have attempted to disrupt this network by the inoculation of anti-CD8 monoclonal antibodies (mAb) in vivo. Intraperitoneal inoculation of three mAbs resulted in a marked increase in the proliferation of CD4+, self-Ia-reactive splenic T cells in vitro to syngeneic, but not to allogeneic, spleen cells. Suppression was not limited to a specific mouse strain as the enhanced SMLR was reproducible following anti-CD8 treatment of three strains of mice. In vivo depletion of CD8+ T cells was not a prerequisite for enhancement of the SMLR as several mAb to CD8 augmented the SMLR independent of their capacity to cause CD8 T cell depletion. Moreover, enhancement of the SMLR could be mimicked in vitro by inclusion of anti-CD8 mAb in in vitro cultures of responder T cells and irradiated Ia+ syngeneic stimulators. Since the in vitro SMLR was enhanced following mAb treatment, it was expected that the in vivo SMLR would also be increased. However, no evidence of increased in vivo autoreactivity could be detected following in vivo treatment with anti-CD8 mAb, indicating that other mechanisms in addition to CD8+ regulatory T cells acted to regulate the in vivo activity of autoreactive T cells.

摘要

该实验室先前的研究表明,CD8 + T抑制(Ts)细胞网络调节小鼠同基因混合淋巴细胞反应(SMLR)。我们试图通过在体内接种抗CD8单克隆抗体(mAb)来破坏这个网络。腹腔注射三种mAb导致体外CD4 +、自身Ia反应性脾T细胞对同基因脾细胞而非异基因脾细胞的增殖显著增加。抑制作用并不局限于特定的小鼠品系,因为对三种品系的小鼠进行抗CD8治疗后,增强的SMLR是可重复的。体内CD8 + T细胞的耗竭不是增强SMLR的先决条件,因为几种抗CD8 mAb增强了SMLR,而与它们导致CD8 T细胞耗竭的能力无关。此外,通过在反应性T细胞和经照射的Ia +同基因刺激物的体外培养物中加入抗CD8 mAb,可以在体外模拟SMLR的增强。由于mAb处理后体外SMLR增强,预计体内SMLR也会增加。然而,在用抗CD8 mAb进行体内治疗后,未检测到体内自身反应性增加的证据,这表明除了CD8 +调节性T细胞外,其他机制也参与调节自身反应性T细胞的体内活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验